Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
- Image -1 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 01
- image-2 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 02
- image-3 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 03
- image-4 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 04
- image-5 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 05
- image-6 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 06
- image-7 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 07
- image-8 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 08
- image-9 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 09
- Label Image - lbl500905802
Product Label Images
The following 10 images provide visual information about the product associated with Sildenafil NDC 50090-5802 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image -1 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 01
image-2 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 02
The text contains a table with the systolic blood pressure readings (in mmHg) for a pre-dose condition and different time points post-dose (in hours) for two treatments- 6-O Sildenafil 100mg and Placebo. No further information is available.*
image-3 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 03
This is a table showing the change in SBP (Systolic Blood Pressure) in mmHg over time postdose in hours. The treatment groups are represented by two columns: OseDoxazosin + Placebo and OseDoxazosin + Sildenafil 25mg. The values for change in SBP are 20 mmHg, -30 mmHg, and 40 mmHg. The time postdose is represented by four rows: 3, 5, [, and 7 hours.*
image-4 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 04
image-5 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 05
This appears to be a table that possibly shows the effects of a drug combination. It includes the blood pressure measurement "mmHg" and has two drug combinations listed: "Doxazosin + Sidenafil 100 mg" and "Doxazosin + Placebo". The numbers 1-3 and 5-8 may refer to measurements taken at different time intervals after dosing. Without additional context, it is difficult to determine the specific meaning or significance of the information presented.*
image-6 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 06
The text describes a graph indicating the plasma concentration in ng/mi over time post-dose (in hours) for a commercial tablet. The graph shows a peak concentration of 450 ng/mi at around 12 hours post-dose, with a steady decrease in concentration over time. At 18 hours post-dose, the concentration has fallen to around 350 ng/mi. The graph also appears to show that at 3 hours post-dose, the concentration is around 20 ng/mi, and at 20 hours post-dose, the concentration is around 2-2.5 ng/mi.*
image-7 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 07
image-8 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 08
image-9 - b55cec96 c673 44ee 8ea7 3465f7bc8e67 09
The text appears to be showing some numerical data related to a medical study or clinical trial. It lists different dosages of three drugs with letters and symbols denoting some percentages and probabilities. The drugs are named Placebo, Sildenafi, Sidenafl, and Sidenafil. There are also counts of patients in different treatment groups. The only clear information is that the overall treatment has a p-value of less than 0.0001, which can indicate strong evidence of an effect.*
Label Image - lbl500905802
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
